Advertisement

Use of Denaturing High-Performance Liquid Chromatography in Molecular Medicine

  • Elizabeth L. Rugg
  • Gareth J. Magee
Protocol
Part of the Springer Protocols Handbooks book series (SPH)

Abstract

The molecular diagnosis of hereditary and somatic disorders is a rapidly expanding field in modern medicine. Mutations in more than 1500 genes have been found to be associated with human diseases, and this figure is likely to rise significantly over the next few years as the genetic basis of more conditions becomes known. DNA sequencing is still probably the most widely used and reliable method of detecting gene mutations and sequence variations. However, it is expensive and time-consuming, and, increasingly, other methods are employed to screen DNA fragments for sequence variations. For a screening method to be useful, it must be fast, inexpensive and applicable to most genes. Ideally, it needs to provide information about the nature and position of a mutation and to minimize exposure of laboratory staff to hazardous reagents. Many of the protocols currently used fit some of these criteria, but there are few, if any, that fulfill all.

Keywords

Sequence Variation Pathogenic Mutation Epidermolysis Bullosa Polymerase Chain Reaction Fragment Familial Hemiplegic Migraine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Xiao, W. and Oefner, P. J. (2001) Denaturing high-performance liquid chromatography: a review. Mutat. 17, 439–474.CrossRefGoogle Scholar
  2. 2.
    Huber, C. G., Oefner, P. J., and Bonn, G. K. (1995) Rapid and accurate sizing of DNA fragments by ion-pair chromatography on alkylated nonporous poly(styrene-divinylbenzene) particles. Anal. Chem. 67, 578–585.CrossRefGoogle Scholar
  3. 3.
    Doris, P. A., Oefner, P. J., Chilton, B. S., and Hayward-Lester, A. (1998) Quantitative analysis of gene expression by ion-pair high-performance liquid chromatography. J. Chromatogr. A 8, 47–60.CrossRefGoogle Scholar
  4. 4.
    Oefner, P. J. (2000) Allelic discrimination by denaturing high-performance liquid chromatography. J. Chromatogr. B: Biomed. Sci. Applic. 739, 345–355.CrossRefGoogle Scholar
  5. 5.
    Arnold, N., Gross, E., Schwarz-Boeger, U., et al. (1999) A highly sensitive, fast, and economical technique for mutation analysis in hereditary breast and ovarian cancers. Hum. Mutat. 14, 333–339.PubMedCrossRefGoogle Scholar
  6. 6.
    Choy, Y. S., Dabora, S. L., Hall, F., et al. (1999) Superiority of denaturing high performance liquid chromatography over single-stranded conformation and conformation-sensitive gel electrophoresis for mutation detection in TSC2. Ann. Hum. Genet. 63(Pt. 5), 383–391.PubMedCrossRefGoogle Scholar
  7. 7.
    O’Donovan, M. C., Oefner, P. J., Roberts, S. C., et al. (1998) Blind analysis of denaturing highperformance liquid chromatography as a tool for mutation detection. Genomics 52, 44–49.CrossRefGoogle Scholar
  8. 8.
    Jones, A. C., Austin, J., Hansen, N., et al. (1999) Optimal temperature selection for mutation detection by denaturing HPLC and comparison to single-stranded conformation polymorphism and heteroduplex analysis. Clin. Chem. 45, 1133–1140.PubMedGoogle Scholar
  9. 9.
    Lin, D., Goldstein, J. A., Mhatre, A. N., Lustig, L. R., Pfister, M., and Lalwani, A. K. (2001) Assessment of denaturing high-performance liquid chromatography (DHPLC) in screening for mutations in connexin 26 (GJB2). Hum. Mutat. 18, 42–51.PubMedCrossRefGoogle Scholar
  10. 10.
    Rugg, E. L., Common, J. E., Wilgoss, A., et al. (2002) Diagnosis and confirmation of epidermolytic palmoplantar keratoderma by the identification of mutations in keratin 9 using denaturing highperformance liquid chromatography. Br. J. Dermatol. 146, 952–957.PubMedCrossRefGoogle Scholar
  11. 11.
    Frueh, F. W. and Noyer-Weidner, M. (2003) The use of denaturing high-performance liquid chromatography (DHPLC) for the analysis of genetic variations: impact for diagnostics and pharmacogenetics. Clin. Chem. Lab. Med. 41, 452–461.PubMedCrossRefGoogle Scholar
  12. 12.
    Ellis, L. A., Taylor, C. F., and Taylor, G. R. (2000) A comparison of fluorescent SSCP and denaturing HPLC for high throughput mutation scanning. Hum. Mutat. 15, 556–564.PubMedCrossRefGoogle Scholar
  13. 13.
    Ophoff, R. A., Terwindt, G. M., Vergouwe, M. N., et al. (1996) Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 87, 543–552.PubMedCrossRefGoogle Scholar
  14. 14.
    Oldenburg, J., Ivaskevicius, V., Rost, S., et al. (2001) Evaluation of DHPLC in the analysis of hemophilia A. J. Biochem. Biophys. Methods 47, 39–51.PubMedCrossRefGoogle Scholar
  15. 15.
    Frusconi, S., Passerini, I., Girolami, F., et al. (2002) Identification of seven novel mutations of F8C by DHPLC. Hum. Mutat. 20, 231–232.PubMedCrossRefGoogle Scholar
  16. 16.
    Bogdanova, N., Markoff, A., Pollmann, H., et al. (2002) Prevalence of small rearrangements in the factor VIII gene F8C among patients with severe hemophilia A. Hum. Mutat. 20, 236–237.PubMedCrossRefGoogle Scholar
  17. 17.
    Castaldo, G., Nardiello, P., Bellitti, F., et al. (2003) Haemophilia B: from molecular diagnosis to gene therapy. Clin. Chem. Lab. Med. 41, 445–451.PubMedCrossRefGoogle Scholar
  18. 18.
    Liu, W., Smith, D. I., Rechtzigel, K. J., Thibodeau, S. N., and James, C. D. (1998) Denaturing high performance liquid chromatography (DHPLC) used in the detection of germline and somatic mutations. Nucleic Acids Res. 26, 1396–1400.PubMedCrossRefGoogle Scholar
  19. 19.
    Le Marechal, C., Audrezet, M. P., Quere, I., Raguenes, O., Langonne, S., and Ferec, C. (2001) gene by denaturing high-performance liquid chromatography (D-HPLC): major implications for genetic counselling. Hum. Genet. 108, 290–298.PubMedCrossRefGoogle Scholar
  20. 20.
    Audrezet, M. P., Chen, J. M., Le Marechal, C., et al. (2002) Determination of the relative contribution of three genes-the cystic fibrosis transmembrane conductance regulator gene, the cationic trypsinogen gene, and the pancreatic secretory trypsin inhibitor gene-to the etiology of idiopathic chronic pancreatitis. Eur. J. Hum. Genet. 10, 100–106.PubMedCrossRefGoogle Scholar
  21. 21.
    Ravnik-Glavac, M., Atkinson, A., Glavac, D., and Dean, M. (2002) DHPLC screening of cystic fibrosis gene mutations. Hum. Mutat. 19, 374–383.PubMedCrossRefGoogle Scholar
  22. 22.
    Scotet, V., Gillet, D., Dugueperoux, I., et al. (2002) Spatial and temporal distribution of cystic fibrosis and of its mutations in Brittany, France: a retrospective study from 1960. Hum. Genet. 111, 247–254.PubMedCrossRefGoogle Scholar
  23. 23.
    Girardet, A., Cathala, P., and Claustres, M. (2003) Rapid detection of the deltaF508 mutation in single cells using DHPLC: implications for preimplantation genetic diagnosis. J. Assist. Reprod. Genet. 20, 153–156.PubMedCrossRefGoogle Scholar
  24. 24.
    Kelsell, D. P., Wilgoss, A. L., Richard, G., Stevens, H. P., Munro, C. S., and Leigh, I. M. (2000) Connexin mutations associated with palmoplantar keratoderma and profound deafness in a single family. Eur. J. Hum. Genet. 8, 141–144.PubMedCrossRefGoogle Scholar
  25. 25.
    Weigell-Weber, M., Schinzel, A., and Hergersberg, M. (2000) Hereditary hearing loss due to mutations in the connexin-26 gene. Schweiz. Med. Wochenschr. 130, 1072–1077.PubMedGoogle Scholar
  26. 26.
    Pallares-Ruiz, N., Blanchet, P., Mondain, M., et al. (2001) Evaluation of dHPLC for CX26 mutation screening in patients from southern France with sensorineural deafness. Genet. Test. 5, 339–343.PubMedCrossRefGoogle Scholar
  27. 27.
    Mhatre, A. N., Weld, E., and Lalwani, A. K. (2003) Mutation analysis of Connexin 31 (GJB3) in sporadic non-syndromic hearing impairment. Clin. Genet. 63, 154–159.PubMedCrossRefGoogle Scholar
  28. 28.
    Takashima, H., Boerkoel, C. F., and Lupski, J. R. (2001) Screening for mutations in a genetically heterogeneous disorder: DHPLC versus DNA sequence for mutation detection in multiple genes causing Charcot-Marie-Tooth neuropathy. Genet. Med. 3, 335–342.PubMedCrossRefGoogle Scholar
  29. 29.
    Jacobsen, N. J., Lyons, I., Hoogendoorn, B., et al. (1999) ATP2A2 mutations in Darier’s disease and their relationship to neuropsychiatric phenotypes. Hum. Mol. Genet. 8, 1631–1636.PubMedCrossRefGoogle Scholar
  30. 30.
    Bitoun, E., Chavanas, S., Irvine, A. D., et al. (2002) Netherton syndrome: disease expression and spectrum of SPINK5 mutations in 21 families. J. Invest. Dermatol. 118, 352–361.PubMedCrossRefGoogle Scholar
  31. 31.
    Pfendner, E. G., Nakano, A., Pulkkinen, L., Christiano, A. M., and Uitto, J. (2003) Prenatal diagnosis for epidermolysis bullosa: a study of 144 consecutive pregnancies at risk. Prenat. Diagn. 23, 447–456.PubMedCrossRefGoogle Scholar
  32. 32.
    Wilgoss, A., Leigh, I. M., Barnes, M. R., et al. (1999) Identification of a novel mutation R42P in the gap junction protein beta-3 associated with autosomal dominant erythrokeratoderma variabilis. J. Invest. Dermatol. 113, 1119–1122.PubMedCrossRefGoogle Scholar
  33. 33.
    Terron-Kwiatkowski, A., Paller, A. S., Compton, J., Atherton, D. J., McLean, W. H., and Irvine, A. D. (2002) Two cases of primarily palmoplantar keratoderma associated with novel mutations in keratin 1. J. Invest. Dermatol. 119, 966–971.PubMedCrossRefGoogle Scholar
  34. 34.
    Rabionet, R., Gasparini, P., and Estivill, X. (2000) Molecular genetics of hearing impairment due to mutations in gap junction genes encoding beta connexins. Hum. Mutat. 16, 190–202.PubMedCrossRefGoogle Scholar
  35. 35.
    Leonard, D. G., Travis, L. B., Addya, K., et al. (2002) p53 mutations in leukemia and myelodysplastic syndrome after ovarian cancer. Clin. Cancer Res. 8, 973–985.PubMedGoogle Scholar
  36. 36.
    Jones, A. C., Sampson, J. R., and Cheadle, J. P. (2001) Low level mosaicism detectable by DHPLC but not by direct sequencing. Hum. Mutat. 17, 233–234.PubMedCrossRefGoogle Scholar
  37. 37.
    Gross, E., Kiechle, M., and Arnold, N. (2001) Mutation analysis of p53 in ovarian tumors by DHPLC. J. Biochem. Biophys. Methods 47, 73–81.PubMedCrossRefGoogle Scholar
  38. 38.
    Keller, G., Hartmann, A., Mueller, J., and Hofler, H. (2001) Denaturing high pressure liquid chromatography (DHPLC) for the analysis of somatic p53 mutations. Lab. Invest. 81, 1735–1737.PubMedGoogle Scholar
  39. 39.
    Quintanilla-Martinez, L., Kremer, M., Keller, G., et al. (2001) p53 Mutations in nasal natural killer/ T-cell lymphoma from Mexico: association with large cell morphology and advanced disease. Am. J. Pathol. 159, 2095–2105.PubMedCrossRefGoogle Scholar
  40. 40.
    Breton, J., Sichel, F., Abbas, A., Marnay, J., Arsene, D., and Lechevrel, M. (2003) Simultaneous use of DGGE and DHPLC to screen TP53 mutations in cancers of the esophagus and cardia from a European high incidence area (Lower Normandy, France). Mutagenesis 18, 299–306.PubMedCrossRefGoogle Scholar
  41. 41.
    Athma, P., Rappaport, R., and Swift, M. (1996) Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet. Cytogenet. 92, 130–134.PubMedCrossRefGoogle Scholar
  42. 42.
    Bernstein, J. L., Teraoka, S., Haile, R. W., et al. (2003) Designing and implementing quality control for multi-center screening of mutations in the ATM gene among women with breast cancer. Hum. Mutat. 21, 542–550.PubMedCrossRefGoogle Scholar
  43. 43.
    Chinnery, P. F., Howell, N., Andrews, R. M., and Turnbull, D. M. (1999) Clinical mitochondrial genetics. J. Med. Genet. 36, 425–436.PubMedGoogle Scholar
  44. 44.
    van Den Bosch, B. J., de Coo, R. F., Scholte, H. R., et al. (2000) Mutation analysis of the entire mitochondrial genome using denaturing high performance liquid chromatography. Nucleic Acids Res. 28, E89.CrossRefGoogle Scholar
  45. 45.
    Shinka, T., Naroda, T., Tamura, T., Sasahara, K., and Nakahori, Y. (2001) A rapid and simple method for sex identification by heteroduplex analysis, using denaturing high-performance liquid chromatography (DHPLC). J. Hum. Genet. 46, 263–266.PubMedCrossRefGoogle Scholar
  46. 46.
    LaBerge, G. S., Shelton, R. J., and Danielson, P. B. (2003) Forensic utility of mitochondrial DNA analysis based on denaturing high-performance liquid chromatography. Croat. Med. J. 44, 281–288.PubMedGoogle Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2005

Authors and Affiliations

  • Elizabeth L. Rugg
    • 1
  • Gareth J. Magee
    • 2
    • 3
  1. 1.Department of DermatologyUniversity of CaliforniaIrvine
  2. 2.Centre for Cutaneous Research, Barts and the London, Queen Mary’s School of Medicine and DentistryUniversity of LondonLondonUK
  3. 3.Biomedical Research CentreNinewells Hospital and Medical SchoolDundee, ScotlandUK

Personalised recommendations